HIV Rapid Testing Programs in Non-Clinical Settings have the Potential to Constitute a Major Diagnostic Option for MSM in Spain.
We analyze the impact of HIV rapid testing (RT) programs in non-clinical settings (NCS) by evaluating their contribution to new diagnoses reported to the Spanish HIV Surveillance System (SINIVIH) from 2007 to 2012. We estimate the proportion of new diagnoses reported to SINIVIH attributable to them and the maximum annual contribution (MAC). Of 95.575 rapid tests conducted, 2061 were reactive; 1582 in men who have sex with men (MSM). The contribution of RT in NCS increased from 3.4% in 2007 to 11.0% in 2012 (8.1%-16.6% in MSM). RT programs contributed 25.3% of the new diagnoses reported in Catalonia (MAC:30.6%), 15% in the Canary Islands (MAC:16.2%) and 13.7% in the Basque Country (MAC:21.0%). Among MSM, contribution was of 45.2% in Catalonia (MAC:60.7%), 20.2% in the Canary Islands (MAC:21.3%) and 16.6% in the Basque country (MAC:20.9%). Especially among MSM, RT in NCS contributed a large proportion of the new HIV cases diagnosed in regions with a very high HIV incidence.
CIBER de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
Sonia Fernández
SF
Balbuena
CIBER de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain. jhoyos@externos.isciii.es.|Departamento de Epidemiología y Bioestadística, Escuela Nacional de Sanidad, Instituto de salud Carlos III, Madrid, Spain. jhoyos@externos.isciii.es.
Juan
http://orcid.org/0000-0003-3772-2771
J
Hoyos
CIBER de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.|Departamento de Epidemiología y Bioestadística, Escuela Nacional de Sanidad, Instituto de salud Carlos III, Madrid, Spain.
María José
MJ
Belza
Projecte dels NOMS Hispanosida, BCN Checkpoint, Barcelona, Spain.
Ferran
F
Pujol
Asociación Madrid Positivo, Madrid, Spain.
Jorge
J
Álvarez
Osakidetza-Servicio Vasco de Salud, San Sebastián, Spain.
Daniel
D
Zulaica
Consejería de Salud de la Junta de Andalucía, Seville, Spain.
Carmen
C
Zamora
Agencia de Salud Pública de Barcelona, Barcelona, Spain.
Benet
B
Rifá
Agencia de Salud Pública de Barcelona, Barcelona, Spain.
Patricia
P
García-de-Olalla
Médicos del Mundo, Madrid, Spain.
Ramón
R
Esteso
Sidálava-Comisión Ciudadana Antisida de Álava, Vitoria, Spain.
Blanca
B
Bastida
Dirección General de Salud Pública, Consejería de Sanidad, Valladolid, Spain.
María Del Henar
MD
Marcos
Alas-Associacio de lluita anti-sida de les Illes ballears, Palma de Mallorca, Spain.
Joan
J
Viver
Lambda Colectiu de lesbians, gais, transsexuals i bisexuals, Valencia, Spain.
Julia
J
Talavera
Dirección de Salud Pública del Servicio Canario de la Salud, Santa Cruz de Tenerife, Spain.
Lourdes
L
Capote
Plan galego antiVIH/sida e outras ITS, A Coruña, Spain.
Rogelio
R
Lema
Bizkaisida, Comisión Ciudadana Antisida de Bizkaia, Bilbao, Spain.
Marta
M
Pastor
CIBER de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.|Centro Nacional de Epidemiología, Instituto de Salud Carlos III, Madrid, Spain.
Luis
L
de la Fuente
D003695:Delivery of Health Care; D015658:HIV Infections / Q000175:diagnosis* / Q000453:epidemiology; D006801:Humans; D015994:Incidence; D008297:Male; D008403:Mass Screening; D000072339:Sexual and Gender Minorities; D013030:Spain / Q000453:epidemiology
Diagnosis; Epidemiology; HIV infection; Public health